Amylin Pharmaceuticals, Inc. (AMLN) and Alkermes plc (ALKS) recently announced the availability of their type II diabetes treatment, Bydureon (exenatide once-weekly) in the US...

The Alliance for Continuing Education in the Health Professions annual conference in January included a session on on risk evaluation and mitigation strategy, or REMS, for long-acting and extended-release opioids...
Bayer HealthCare is working with the Ludwig Boltzmann Institute (LBI) for Lung Vascular Research in the research area of lung vascular diseases - especially pulmonary hypertension...

REMS Daily Archives

 

Next page: REMS Events
 
Register for periodic industry updates:

2017© 2015 ParagonRx. All rights reserved.